All Updates

Today, the U.S. Food and Drug Administration (FDA) released a proposed rule on front-of-package (FOP) nutrition labels, that would mandate a nutrition information box on the front of food packages to complement the existing required Nutrition Facts label.

CHEYENNE, Wyo. – As legislative business convenes today in the state capitol, lawmakers must prioritize access to health care so that tens of thousands of Wyomingites can continue to lead healthy and happy lives and have the best chance to avoid, detect and defeat cancer. Regular visits to health care

PIERRE, S.D. – South Dakota legislators begin a new session today and American Cancer Society Cancer Action Network advocates will urge them to take the opportunity to assure those at risk for breast cancer have the tools needed for early detection and defeat of the disease. Regular mammograms are an

As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

NASHVILLE, Tenn. – As Tennessee lawmakers begin the 2025 legislative session Tuesday, the American Cancer Society Cancer Action Network (ACS CAN) urges them to prioritize legislation which would allow more Tennesseans to access biomarker testing, an increasingly important part of cancer care. In the case of a cancer

COLUMBIA, S.C. – As the 2025 legislative session begins Tuesday, the American Cancer Society Cancer Action Network (ACS CAN) urges lawmakers to support policies that will reduce the cancer burden in the Palmetto State. ACS CAN South Carolina Government Relations Director Beth Johnson released the following statement: “We

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023.